Enovix (NASDAQ:ENVX) Cut to Hold at Craig Hallum

Craig Hallum cut shares of Enovix (NASDAQ:ENVX – Free Report) from a buy rating to a hold rating in a research note published on Friday morning, Marketbeat reports. Craig Hallum currently has $2.00 price target on the stock.

Several other research firms also recently issued reports on ENVX. Wall Street Zen downgraded shares of Enovix from a “sell” rating to a “strong sell” rating in a research report on Saturday, October 31st. B. Riley Financial decreased their price target on shares of Enovix from $8.00 to $7.20 and set a “buy” rating for the company in a research note on Thursday, August 13th. Cantor Fitzgerald restated an “overweight” rating and set a $20.00 price objective on shares of Enovix in a report on Thursday, August 13th. Canaccord Genuity Group dropped their price objective on shares of Enovix from $12.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research note on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $7.80.

Get Our Latest Stock Analysis on ENVX

Enovix Price Performance

Enovix stock opened at $1.60 on Friday. The company has a market capitalization of $351.12 million, a PE ratio of -2.19 and a beta of 2.34. Enovix has a 12-month low of $1.53 and a 12-month high of $9.19. The firm’s fifty day moving average is $2.23 and its 200 day moving average is $3.93. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46.

Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings data on Friday, November 13th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.05. Enovix had a negative net margin of 406.54% and a negative return on equity of 67.80%. The firm had revenue of $11.04 million for the quarter. As a group, sell-side analysts predict that Enovix will post -0.79 EPS for the current fiscal year.

Institutional Investors Weigh In On Enovix

Institutional investors have recently bought and sold shares of the stock. Jump Financial LLC lifted its stake in Enovix by 185.1% during the 3rd quarter. Jump Financial LLC now owns 1,596,042 shares of the company’s stock valued at $4,629,000 after acquiring an additional 1,036,189 shares in the last quarter. Caxton Associates LLP purchased a new position in Enovix during the 3rd quarter worth $117,000. First Trust Advisors LP boosted its holdings in Enovix by 32.3% during the 3rd quarter. First Trust Advisors LP now owns 774,813 shares of the company’s stock worth $2,247,000 after acquiring an additional 188,954 shares during the last quarter. HighTower Advisors LLC boosted its holdings in Enovix by 18.9% during the 3rd quarter. HighTower Advisors LLC now owns 70,900 shares of the company’s stock worth $206,000 after acquiring an additional 11,285 shares during the last quarter. Finally, Vista Capital Partners Inc. bought a new stake in shares of Enovix in the 3rd quarter worth $284,000. Institutional investors own 50.92% of the company’s stock.

Key Enovix News

Here’s some of the latest news about ENVX:

  • Positive Sentiment: The company plans to invest $19 million to double drone-battery capacity at its South Korean facility, while its drone, defense and industrial pipeline grew 18% sequentially to about $216 million. It also reported $512 million in cash, cash equivalents, marketable securities and restricted cash, and retired $128 million face value of convertible notes for about $81 million. Enovix Q3 results and outlook
  • Negative Sentiment: Law firms announced investigations into whether Enovix misled investors, including about the readiness of its AI-1 silicon-anode cells for phone qualification. The announcements followed a steep share-price decline and may add uncertainty, although they do not establish that securities laws were violated. Block & Leviton investigation announcement
  • Negative Sentiment: Fourth-quarter revenue guidance of $9 million–$10 million is below the just-reported third-quarter revenue, raising near-term concerns about growth and execution despite the stronger FY2027 outlook. Enovix Q3 results and outlook

About Enovix

(Get Free Report)

Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company’s batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.

Featured Articles

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.